TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
TCL Archive In Brief: Appropriations Bill Markups Due This Month, With Increases Seen For NCI, NIH, And AIDS July 3, 1987
TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
